| ITEM | FY 95 | FY 96 | FY 97 | FY 98 | FY 99 | FY 00 | FY 01 | FY 02 | FY 03 | FY 04 | FY 05 | FY 06 | FY 07 |
| Licensing FTE1 | 0.4 | 1.3 | 1.0 | 1.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.0 | 2.5 | 3.5 | 3.5 |
| Invention Disclosures2 | 24 | 7 | 16 | 14 | 23 | 22 | 25 | 17 | 28 | 50 | 41 | 39 | 39 |
| Patent Applications | 17 | 8 | 11 | 22 | 15 | 33 | 34 | 34 | 41 | 58 | 50 | 52 | 64 |
| U.S. Patents Granted | 7 | 8 | 10 | 15 | 5 | 16 | 7 | 15 | 18 | 22 | 19 | 11 | 19 |
| Licenses Signed | 2 | 3 | 7 | 9 | 8 | 9 | 11 | 10 | 12 | 6 | 11 | 2 | 13 |
| Active Licenses/Options3 | 9 | 6 | 11 | 10 | 14 | 23 | 31 | 39 | 42 | 47 | 57 | 37 | 50 |
| Yearly R&D Commitments4 | - | - | $193,002 | $430,534 | $428,837 | $568,881 | $1,146,446 | $3,809,155 | $1,452,814 | $3,345,371 | $1,056,279 | $1,041,369 | $1,349,846 |
| Royalties: Patented [Non-Taxol}5 | $273,345 | $425,644 | $882,384 | $1,497,129 | $390,717 | $378,562 | $584,729 | $307,546 | $298,194 | $368,341 | $545,568 | $637,018 | $330,080 |
| Royalties: Non-Patented [Non-Taxol]6 | - | - | - | $27,001 | $109,624 | $821,533 | $838,838 | $953,678 | $467,436 | $243,991 | $563,593 | $678,586 | $1,864,119 |
| Royalties: Total [Non-Taxol]7 | $273,345 | $425,644 | $882,384 | $1,524,130 | $500,341 | $1,200,095 | $1,423,567 | $1,261,224 | $765,630 | $612,332 | $1,109,161 | $1,315,604 | $2,194,199 |
| Revenue: Other8 | - | - | - | - | $20,000 | - | - | - | $13,000 | $180,000 | $180,000 | $160,000 | $300,000 |
| Revenue: Total [Non-Taxol]9 | $273,345 | $425,644 | $1,075,386 | $1,954,664 | $949,178 | $1,768,976 | $2,570,013 | $5,070,374 | $2,231,444 | $4,137,703 | $2,345,441 | $2,516,974 | $3,844,045 |
| Royalty: Taxol10 | $9,586,986 | $6,111,075 | $29,019,776 | $45,147,158 | $56,959,797 | $67,241,277 | $61,497,501 | $38,393,926 | $20,153,897 | $10,381,456 | $1,552,090 | $0.0 | $0.0 |
| FSU R&D Expenditures | $91,294,249 | $87,485,000 | $102,550,000 | $112,078,000 | $132,665,000 | $136,300,000 | $143,245,810 | $154,705,048 | $176,188,199 | $205,199,334 | $191,438,051 | $189,229,916 | $199,000,000 |
Footnotes:
1 FTE is defined by AUTM as persons employed in the technology transfer office whose duties are specifically involved with the licensing and patenting processes as either full or fractional FTE allocations.
2 Starting July 2003 OIPDC changed the way it counts invention disclosures by counting second provisionals, divisionals and continuation patent applications as individual inventions.
3 In fiscal year 2006, 17 Agreement were found to be inactive from prior years
4 Commitments tied to IP, Option Agreements, and License Agreements
5 Patented royalties from patentable IP not related to Taxol
6 Non-patented royalties from licensing copyrightable IP
7 Royalty Total [Non Taxol] = footnotes 5 + 6
8 Other revenue includes donated equipment, patent reimbursements, and various one time items.
9 Revenue Total [Non Taxol] = footnotes 4 + 5 + 6 + 8
10 Gross receipts from Taxol royalties from FY 1993-FY 1994 total $6,608,755
Fiscal Year ends June 30th of the year indicated
Information is compiled from AUTM reports, Office of Research Annual Reports and internal working documents from FSURF and OIPDC.
Click here for a current list of FSU/FSURF Patents.